Home NDC 0480-7250 Liraglutide
Product NDC 0480-7250
11-digit product format 004807250
Labeler code 0480
Product ID 0480-7250_4df44cd9-cb11-46b6-ba6c-88ff963ec414
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Liraglutide
Dosage form INJECTION, SOLUTION
Route SUBCUTANEOUS
Labeler Teva Pharmaceuticals, Inc.
Application ANDA214568
Marketing category ANDA
Marketing start 2025-08-28
Marketing end 2027-09-30
Substance LIRAGLUTIDE
Active strength 6 mg/mL
Pharmacologic classes GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]
NDC exclude flag No
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A214568-001 LIRAGLUTIDE LIRAGLUTIDE 18MG/3ML (6MG/ML) SOLUTION / SUBCUTANEOUS AP2 2025-08-27
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code A214568-001 AP2
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 1 matching rows.
Application-product, Exclusivity code, Expiration table Application-product Exclusivity code Expiration A214568-001 PC 2026-02-24
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 A214568-001 LIRAGLUTIDE 18MG/3ML (6MG/ML) SOLUTION / SUBCUTANEOUS AP2 2025-08-27 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A214568-001 LIRAGLUTIDE 18MG/3ML (6MG/ML) SOLUTION / SUBCUTANEOUS AP2 2025-08-27 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A214568-001 LIRAGLUTIDE 18MG/3ML (6MG/ML) SOLUTION / SUBCUTANEOUS AP2 2025-08-27 31067a03dcf5…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A214568-001 LIRAGLUTIDE 18MG/3ML (6MG/ML) SOLUTION / SUBCUTANEOUS AP2 2025-08-27 a50c72e98297…
Observed Orange Book normalized TE history# Captured, Edition, Application-product table Captured Edition Application-product TE code Order Source SHA-256 2026-08-18 06:07:40 2026-07 A214568-001 AP2 1 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A214568-001 AP2 1 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A214568-001 AP2 1 31067a03dcf5…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A214568-001 AP2 1 a50c72e98297…
Observed Orange Book exclusivity history# Captured, Edition, Application-product table Captured Edition Application-product Exclusivity code Expiration Source SHA-256 2026-08-18 06:07:40 2026-07 A214568-001 PC 2026-02-24 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A214568-001 PC 2026-02-24 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A214568-001 PC 2026-02-24 31067a03dcf5…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A214568-001 PC 2026-02-24 a50c72e98297…
Additional Listing Data#
Finished product Yes
Brand name base Liraglutide Active Ingredients# Ingredient, Strength table Ingredient Strength LIRAGLUTIDE 6 mg/mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 839I73S42A Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 2735350 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 0480-7250-46 Liraglutide 3 mL in 1 SYRINGE, PLASTIC INJECTION, SOLUTION 3 4 0480-7250-46 Liraglutide 5 in 1 CARTON INJECTION, SOLUTION 5 4
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 0480-7250-46 00480725046 5 SYRINGE, PLASTIC in 1 CARTON (0480-7250-46) / 3 mL in 1 SYRINGE, PLASTIC 2025-08-28 2027-09-30 No No Historical